Cargando…
Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with futur...
Autores principales: | Kunutsor, Setor K., Kieneker, Lyanne M., Burgess, Stephen, Bakker, Stephan J.L., Dullaart, Robin P.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721749/ https://www.ncbi.nlm.nih.gov/pubmed/29133521 http://dx.doi.org/10.1161/JAHA.117.006503 |
Ejemplares similares
-
Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
por: Kunutsor, Setor K., et al.
Publicado: (2019) -
Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017) -
Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018) -
HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021) -
Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study
por: Minović, Isidor, et al.
Publicado: (2020)